ARCHIVES

FDA Expands Gleevec Indication For Children with Ph+ ALL

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

Personal letters: mixed reviews of Donald Pinkel’s article on Childhood Lymphocytic Leukemia

May 6, 2021

Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study

January 28, 2011

Biopsy System Effective In Removing Benign Breast Masses, Study Finds

May 28, 2004

NIH Scientists Engineer Mice That Get Burkitt’s Lymphoma.

October 20, 2000

CCOP Application Now Total 180 Plus

November 26, 1982

In Brief: Norman Sharpless Named Director of UNC Lineberger

September 6, 2013